SmartFem is an Australian medical technology company pioneering regenerative treatments for women’s pelvic floor disorders.
SmartFem’s graft system is designed to support natural tissue repair using a woman’s own biological material – without the use of synthetic mesh.”
Based on our preliminary findings:
Our single-use surgical kit supports pelvic organ prolapse repair by creating a personalised graft during surgery, derived from the
patient’s own blood.
This graft provides support to accelerate the healing process and augment tissue repair.
Join clinicians across Australia and soon the world, by adopting a regenerative, evidence-backed graft system that integrates seamlessly with your existing surgical technique.
SmartFem gives women and their clinicians a smarter choice for pelvic organ prolapse repair.
Mesh-based repair has a high complication rate, while native tissue repair can have a high recurrence rate.
SmartFem offers a regenerative, biologically personalised solution designed to integrate with a woman’s own body to promote healthy tissue regeneration and accelerate healing.
A small blood sample is collected
It’s processed using a centrifuge
Two soft-tissue grafts are created during surgery
Grafts are applied to reinforce the repair site
The body naturally integrates the graft over coming weeks as it healed
SmartFem is an Australian medtech company that’s redefining pelvic organ prolapse surgery with science-led, regenerative solutions that put patients first.
Our team blends surgical expertise, clinical research, and engineering innovation.
We partner with:
Join the growing network of clinicians and hospitals using SmartFem
Ask your clinician if SmartFem is
right for you
